NEOMYCIN OINTMENT

NEOMYCIN OINTMENT was reported 2452 times

NEOMYCIN OINTMENT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 C-REACTIVE PROTEIN 286 0.3085
1 DEEP VEIN THROMBOSIS POSTOPERATIVE 310 0.1548
2 SWOLLEN JOINT COUNT INCREASED 466 0.1460
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 80 0.1198
4 SWOLLEN JOINT COUNT 29 0.1160
5 RHEUMATIC FEVER 500 0.1121
6 FACET JOINT SYNDROME 360 0.1105
7 LUPUS VULGARIS 129 0.1024
8 BLOOD METHANOL INCREASED 2 0.1000
9 X-RAY ABNORMAL 169 0.0944
10 RETINITIS 159 0.0920
11 GRIP STRENGTH 20 0.0873
12 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 2 0.0870
13 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 47 0.0838
14 RHEUMATOID FACTOR POSITIVE 445 0.0770
15 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 471 0.0725
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 150 0.0723
17 ACQUIRED PORPHYRIA 5 0.0704
18 SERONEGATIVE ARTHRITIS 79 0.0689
19 DISLOCATION OF VERTEBRA 153 0.0670
20 DUODENAL ULCER PERFORATION 486 0.0653
21 C-REACTIVE PROTEIN ABNORMAL 379 0.0590
22 OTITIS MEDIA BACTERIAL 2 0.0571
23 PORPHYRIA ACUTE 72 0.0502
24 LIP DRY 439 0.0483
25 HELICOBACTER INFECTION 485 0.0471
26 FOLLICULITIS 471 0.0449
27 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 300 0.0418
28 PERIPHERAL VENOUS DISEASE 162 0.0396
29 BLOOD SMEAR TEST ABNORMAL 3 0.0375
30 HAND DEFORMITY 477 0.0363
31 VAGINAL FLATULENCE 11 0.0363
32 MUSCLE INJURY 286 0.0345
33 HYPOCHOLESTEROLAEMIA 12 0.0340
34 BONE EROSION 119 0.0336
35 NASAL OEDEMA 59 0.0326
36 TOXIC ANTERIOR SEGMENT SYNDROME 35 0.0321
37 SCIATICA 483 0.0303
38 AUTOIMMUNE DISORDER 289 0.0296
39 VARICELLA VIRUS TEST POSITIVE 5 0.0294
40 ACANTHAMOEBA KERATITIS 1 0.0270
41 PEMPHIGUS 336 0.0268
42 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 6 0.0267
43 JOINT RANGE OF MOTION DECREASED 353 0.0263
44 SYNOVITIS 452 0.0250
45 LIVE BIRTH 206 0.0246
46 GLOSSODYNIA 483 0.0216
47 IRRITABLE BOWEL SYNDROME 457 0.0213
48 HUMAN BOCAVIRUS INFECTION 4 0.0212
49 SPONDYLITIS 76 0.0209
50 FIBROMYALGIA 487 0.0200
51 EYELID RETRACTION 2 0.0200
52 DRUG TOLERANCE DECREASED 56 0.0199
53 MATERNAL EXPOSURE TIMING UNSPECIFIED 74 0.0197
54 WOUND INFECTION 208 0.0190
55 ANAL EROSION 2 0.0182
56 PERICARDITIS 297 0.0177
57 HYPERCHOLESTEROLAEMIA 169 0.0175
58 WOUND 488 0.0174
59 GRIP STRENGTH DECREASED 149 0.0169
60 SUBCORNEAL PUSTULAR DERMATOSIS 2 0.0161
61 TYPE 2 DIABETES MELLITUS 540 0.0160
62 RED BLOOD CELL SEDIMENTATION RATE INCREASED 175 0.0158
63 EXOSTOSIS 142 0.0155
64 LUPUS-LIKE SYNDROME 141 0.0155
65 ACINETOBACTER TEST POSITIVE 3 0.0155
66 BURSITIS 187 0.0154
67 IMPAIRED HEALING 485 0.0148
68 SYSTEMIC LUPUS ERYTHEMATOSUS 523 0.0147
69 LOWER LIMB FRACTURE 281 0.0146
70 BREAST CANCER STAGE III 92 0.0142
71 ADDISON'S DISEASE 2 0.0139
72 WALKING AID USER 89 0.0135
73 HEPATIC ENZYME 2 0.0134
74 GASTROINTESTINAL BACTERIAL OVERGROWTH 8 0.0133
75 STOMA CLOSURE 4 0.0129
76 PUSTULAR PSORIASIS 43 0.0125
77 LIVER INJURY 306 0.0125
78 BREAST CANCER STAGE II 103 0.0124
79 PSORIATIC ARTHROPATHY 478 0.0118
80 JOINT DESTRUCTION 18 0.0116
81 JOINT DISLOCATION 118 0.0112
82 PROCTECTOMY 3 0.0109
83 ROAD TRAFFIC ACCIDENT 456 0.0109
84 FOOT DEFORMITY 119 0.0107
85 DAIRY INTOLERANCE 3 0.0107
86 SPINAL FUSION SURGERY 42 0.0103
87 LIVER DISORDER 457 0.0103
88 ANTIPHOSPHOLIPID ANTIBODIES 2 0.0103
89 SJS-TEN OVERLAP 7 0.0100
90 STAPHYLOCOCCAL SKIN INFECTION 12 0.0098
91 HIP ARTHROPLASTY 148 0.0097
92 PRESCRIBED UNDERDOSE 190 0.0095
93 PRESCRIBED OVERDOSE 180 0.0093
94 OBESITY 147 0.0092
95 COLORECTAL ADENOCARCINOMA 2 0.0089
96 PULMONARY FIBROSIS 167 0.0087
97 RASH VESICULAR 42 0.0087
98 DEATH NEONATAL 12 0.0086
99 STOMATITIS 521 0.0086
100 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
101 WHEEZING 503 0.0085
102 INFUSION RELATED REACTION 562 0.0085
103 NIGHT SWEATS 273 0.0085
104 BLOOD CHOLESTEROL 4 0.0084
105 ABDOMINAL WALL CYST 1 0.0082
106 NEPHROGENIC ANAEMIA 38 0.0082
107 ILL-DEFINED DISORDER 477 0.0078
108 HYPERPARATHYROIDISM SECONDARY 19 0.0076
109 INFLAMMATION 391 0.0076
110 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
111 BLOOD CHOLESTEROL INCREASED 341 0.0073
112 INJURY 507 0.0072
113 GAIT INABILITY 241 0.0072
114 OSTEOARTHRITIS 305 0.0072
115 GASTROINTESTINAL CANDIDIASIS 3 0.0072
116 HEPATIC ENZYME INCREASED 485 0.0071
117 CARBUNCLE 2 0.0071
118 FEMALE GENITAL TRACT FISTULA 12 0.0070
119 ONYCHOMADESIS 29 0.0069
120 ABDOMINAL WALL DISORDER 2 0.0069
121 BLEPHAROSPASM 43 0.0068
122 KNEE ARTHROPLASTY 142 0.0067
123 MOBILITY DECREASED 480 0.0067
124 HEPATIC CIRRHOSIS 125 0.0066
125 LOWER RESPIRATORY TRACT INFECTION 302 0.0066
126 NORMAL NEWBORN 36 0.0066
127 SYNOVIAL DISORDER 3 0.0066
128 MECHANICAL URTICARIA 3 0.0064
129 PREGNANCY 128 0.0064
130 VANISHING BILE DUCT SYNDROME 7 0.0063
131 GENERAL SYMPTOM 46 0.0061
132 OEDEMA 329 0.0061
133 INFUSION SITE REACTION 18 0.0060
134 MUSCLE SPASTICITY 74 0.0060
135 THERAPY NON-RESPONDER 267 0.0059
136 BLISTER 325 0.0058
137 DISCHARGE 8 0.0058
138 RHINOCEREBRAL MUCORMYCOSIS 2 0.0058
139 OVERLAP SYNDROME 4 0.0057
140 REBOUND ACID HYPERSECRETION 17 0.0056
141 DRY MOUTH 454 0.0056
142 LUNG DISORDER 273 0.0056
143 ARTHROPATHY 309 0.0056
144 SPLENIC LESION 2 0.0054
145 SWELLING 506 0.0054
146 ACANTHAMOEBA INFECTION 1 0.0053
147 MYOSITIS 47 0.0052
148 DISCOMFORT 313 0.0051
149 EAR PAIN 97 0.0050
150 CONTRAINDICATED PRODUCT ADMINISTERED 151 0.0050
151 HERPES ZOSTER DISSEMINATED 4 0.0050
152 SLEEP DISORDER 349 0.0049
153 EYE INJURY 15 0.0049
154 JOINT STIFFNESS 129 0.0049
155 ARTHROPOD STING 8 0.0048
156 THERAPEUTIC PRODUCT EFFECT DECREASED 212 0.0047
157 SINUSITIS 484 0.0047
158 EAR INFECTION 124 0.0047
159 MUSCULOSKELETAL PAIN 242 0.0046
160 PERINEAL ABSCESS 2 0.0044
161 MULTIPLE DRUG OVERDOSE ACCIDENTAL 2 0.0044
162 CIRRHOSIS ALCOHOLIC 2 0.0044
163 RHEUMATOID ARTHRITIS 488 0.0043
164 URINE LEUKOCYTE ESTERASE POSITIVE 3 0.0043
165 C-REACTIVE PROTEIN INCREASED 155 0.0043
166 DELIRIUM 146 0.0042
167 RADICULOPATHY 11 0.0042
168 GENERAL PHYSICAL HEALTH DETERIORATION 477 0.0041
169 JOINT SWELLING 490 0.0041
170 RESPIRATORY DISORDER 120 0.0040
171 MACULAR DEGENERATION 47 0.0039
172 PROCTITIS 11 0.0039
173 JOINT ARTHROPLASTY 7 0.0039
174 HYPERTRANSAMINASAEMIA 26 0.0037
175 PERIORBITAL CELLULITIS 2 0.0037
176 FREQUENT BOWEL MOVEMENTS 100 0.0037
177 DISABILITY 73 0.0037
178 MUSCULOSKELETAL STIFFNESS 323 0.0037
179 NAIL DISORDER 32 0.0037
180 WEIGHT FLUCTUATION 38 0.0036
181 TENOSYNOVITIS STENOSANS 2 0.0036
182 POSTOPERATIVE ILEUS 2 0.0035
183 ULCER HAEMORRHAGE 24 0.0035
184 SOFT TISSUE SWELLING 2 0.0035
185 DRUG INTOLERANCE 338 0.0035
186 LIVER FUNCTION TEST INCREASED 75 0.0035
187 HYPOAESTHESIA 522 0.0035
188 INFECTION 501 0.0035
189 POLYARTHRITIS 18 0.0034
190 TREATMENT FAILURE 281 0.0034
191 EYE LASER SURGERY 2 0.0034
192 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 58 0.0034
193 OSTEOPOROSIS 139 0.0034
194 ATYPICAL FRACTURE 2 0.0032
195 LIPOHYPERTROPHY 2 0.0032
196 CONTUSION 309 0.0032
197 CHRONIC SINUSITIS 12 0.0032
198 END STAGE RENAL DISEASE 58 0.0032
199 GASTROINTESTINAL DISORDER 283 0.0032
200 URTICARIA 522 0.0031
201 ASTHMA 346 0.0031
202 PERSONALITY DISORDER 8 0.0031
203 DRUG TOLERANCE 15 0.0030
204 KIDNEY FIBROSIS 5 0.0029
205 SUPERFICIAL INJURY OF EYE 3 0.0027
206 PRODUCT LABEL CONFUSION 16 0.0027
207 LIP EROSION 2 0.0027
208 HYPERTENSION 563 0.0027
209 MATERNAL EXPOSURE DURING PREGNANCY 233 0.0026
210 POLYDACTYLY 3 0.0026
211 CORNEAL TRANSPLANT 2 0.0026
212 CHRONIC KIDNEY DISEASE 191 0.0025
213 HYPERSENSITIVITY 463 0.0025
214 RECTAL PROLAPSE 3 0.0025
215 TASTE DISORDER 49 0.0024
216 VARICELLA ZOSTER VIRUS INFECTION 5 0.0024
217 ALLERGY TO CHEMICALS 3 0.0024
218 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
219 DRUG-INDUCED LIVER INJURY 73 0.0023
220 AMNESIA 150 0.0023
221 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
222 MEDICATION ERROR 127 0.0023
223 BACK DISORDER 37 0.0023
224 RENAL TUBULAR ATROPHY 2 0.0023
225 RESPIRATORY TRACT INFECTION 59 0.0023
226 WEIGHT INCREASED 506 0.0023
227 PREGNANCY AFTER POST COITAL CONTRACEPTION 5 0.0022
228 UPPER RESPIRATORY TRACT INFECTION 102 0.0022
229 BONE CONTUSION 2 0.0022
230 ADENOCARCINOMA GASTRIC 2 0.0022
231 ABDOMINAL DISCOMFORT 359 0.0021
232 INTENTIONAL PRODUCT USE ISSUE 182 0.0021
233 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
234 CROSS SENSITIVITY REACTION 2 0.0021
235 NODAL RHYTHM 3 0.0020
236 ONYCHOMYCOSIS 9 0.0020
237 SHOULDER PAIN 2 0.0020
238 PERIPHERAL SWELLING 314 0.0020
239 ULNA FRACTURE 2 0.0020
240 CONFUSIONAL STATE 326 0.0020
241 EXPOSURE DURING PREGNANCY 125 0.0020
242 SKIN OEDEMA 2 0.0020
243 HYPOCHROMIC ANAEMIA 2 0.0020
244 ADVERSE EVENT 178 0.0019
245 BACK INJURY 21 0.0019
246 CHEST PAIN 357 0.0019
247 ASTHMATIC CRISIS 7 0.0019
248 URETEROLITHIASIS 2 0.0019
249 BONE DEMINERALISATION 2 0.0019
250 ASTERIXIS 2 0.0019
251 THERAPEUTIC RESPONSE DECREASED 112 0.0018
252 WHITE BLOOD CELL COUNT INCREASED 70 0.0018
253 NASOPHARYNGITIS 335 0.0018
254 PERIRECTAL ABSCESS 2 0.0018
255 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
256 OPEN WOUND 2 0.0018
257 SUSPECTED OFF LABEL USE 8 0.0018
258 ALOPECIA 344 0.0017
259 ADENOVIRUS INFECTION 5 0.0017
260 COLITIS ULCERATIVE 77 0.0017
261 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29 0.0017
262 GROIN ABSCESS 2 0.0017
263 NEPHROCALCINOSIS 2 0.0017
264 DYSPEPSIA 166 0.0017
265 VAGINAL DISCHARGE 17 0.0017
266 COLON OPERATION 2 0.0017
267 SYMPTOM RECURRENCE 10 0.0017
268 MIGRAINE 159 0.0017
269 ADVERSE DRUG REACTION 149 0.0017
270 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 118 0.0017
271 ADRENAL INSUFFICIENCY 20 0.0016
272 ORAL MUCOSA EROSION 2 0.0016
273 PYREXIA 553 0.0016
274 SWELLING OF EYELID 10 0.0016
275 CAROTID ARTERY DISEASE 2 0.0016
276 LABORATORY TEST ABNORMAL 46 0.0016
277 RECTAL HAEMORRHAGE 66 0.0015
278 COLOSTOMY 3 0.0015
279 TACHYCARDIA 134 0.0015
280 HIRSUTISM 2 0.0015
281 HEPATIC ENCEPHALOPATHY 14 0.0015
282 ABDOMINAL PAIN UPPER 307 0.0015
283 EYELID PAIN 3 0.0015
284 IMMUNODEFICIENCY 22 0.0015
285 EPILEPSY 45 0.0015
286 TYPE IV HYPERSENSITIVITY REACTION 4 0.0015
287 ARTHRITIS 114 0.0014
288 CONGENITAL ANOMALY 11 0.0014
289 DECREASED APPETITE 330 0.0014
290 FEELING HOT 87 0.0014
291 CONNECTIVE TISSUE DISORDER 2 0.0014
292 VISUAL IMPAIRMENT 174 0.0014
293 INSOMNIA 371 0.0014
294 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
295 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2 0.0014
296 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 66 0.0014
297 IMPETIGO 2 0.0013
298 MUSCULAR WEAKNESS 152 0.0013
299 VARICES OESOPHAGEAL 4 0.0013
300 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
301 PRURITUS 502 0.0013
302 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 3 0.0013
303 MALAISE 557 0.0013
304 PNEUMONIA LEGIONELLA 2 0.0012
305 SCLERITIS 2 0.0012
306 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
307 CUSHINGOID 4 0.0012
308 MEMORY IMPAIRMENT 171 0.0012
309 FINGER DEFORMITY 6 0.0012
310 RASH 536 0.0012
311 VOMITING 575 0.0012
312 UNDERDOSE 89 0.0012
313 OEDEMA PERIPHERAL 143 0.0012
314 BLOOD AMYLASE INCREASED 2 0.0012
315 WOUND COMPLICATION 4 0.0012
316 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
317 ABSCESS DRAINAGE 1 0.0012
318 ABDOMINAL SEPSIS 1 0.0011
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
320 COELIAC DISEASE 11 0.0011
321 FLUID RETENTION 57 0.0011
322 ULCERATIVE KERATITIS 3 0.0011
323 OESOPHAGEAL SPASM 2 0.0011
324 PNEUMOPERITONEUM 2 0.0011
325 ANXIETY 304 0.0011
326 PANCREATITIS 56 0.0011
327 MUSCLE SPASMS 194 0.0011
328 HYPOPROTEINAEMIA 2 0.0011
329 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
330 CONJUNCTIVITIS 19 0.0010
331 WOUND SECRETION 4 0.0010
332 UNDERWEIGHT 2 0.0010
333 PARAESTHESIA 159 0.0010
334 RENAL INJURY 30 0.0010
335 CONDITION AGGRAVATED 305 0.0010
336 HYPERAMMONAEMIA 5 0.0010
337 BODY TEMPERATURE INCREASED 20 0.0010
338 PSORIASIS 128 0.0010
339 AMMONIA INCREASED 5 0.0010
340 GASTROOESOPHAGEAL REFLUX DISEASE 78 0.0010
341 ARTHRALGIA 401 0.0010
342 GAIT DISTURBANCE 184 0.0010
343 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
344 PRODUCT USE IN UNAPPROVED INDICATION 231 0.0009
345 ATELECTASIS 9 0.0009
346 EXOPHTHALMOS 2 0.0009
347 INTESTINAL RESECTION 5 0.0009
348 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
349 SKIN REACTION 13 0.0009
350 BRONCHITIS 68 0.0009
351 RENAL TUBULAR NECROSIS 9 0.0009
352 MUCOSAL INFLAMMATION 24 0.0009
353 CORNEAL DISORDER 2 0.0009
354 ORAL CANDIDIASIS 12 0.0009
355 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
356 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
357 ABDOMINAL PAIN 209 0.0009
358 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
359 WOUND DEHISCENCE 3 0.0009
360 CYST 11 0.0009
361 CHRONIC GASTRITIS 2 0.0009
362 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
363 DIFFICULTY IN WALKING 3 0.0009
364 ACUTE KIDNEY INJURY 131 0.0009
365 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
366 ESCHERICHIA BACTERAEMIA 2 0.0008
367 PRODUCT USE ISSUE 159 0.0008
368 RENAL FAILURE 112 0.0008
369 RECALLED PRODUCT ADMINISTERED 8 0.0008
370 IMMUNE SYSTEM DISORDER 11 0.0008
371 PNEUMONIA 270 0.0008
372 RADIUS FRACTURE 2 0.0008
373 PARAESTHESIA ORAL 12 0.0008
374 PULSE ABNORMAL 2 0.0008
375 HEPATITIS C 10 0.0008
376 ASTHENIA 307 0.0008
377 VENOOCCLUSIVE DISEASE 2 0.0008
378 PROTEIN TOTAL DECREASED 3 0.0008
379 SYSTEMIC CANDIDA 2 0.0008
380 DEPRESSION 180 0.0008
381 PARKINSON'S DISEASE 2 0.0008
382 DIABETIC COMPLICATION 2 0.0008
383 INCREASED BRONCHIAL SECRETION 2 0.0008
384 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
385 OPTIC NEURITIS 7 0.0008
386 ABDOMINAL OPERATION 1 0.0008
387 ANHEDONIA 20 0.0008
388 HYPERPHAGIA 3 0.0008
389 MULTI-ORGAN FAILURE 13 0.0008
390 PAIN 461 0.0007
391 FATIGUE 584 0.0007
392 AREFLEXIA 2 0.0007
393 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
394 BLOOD SODIUM INCREASED 2 0.0007
395 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
396 ABSCESS ORAL 1 0.0007
397 RHINALGIA 2 0.0007
398 RHEUMATOID NODULE 2 0.0007
399 TENOSYNOVITIS 2 0.0007
400 PLEURITIC PAIN 2 0.0007
401 SECRETION DISCHARGE 9 0.0007
402 WEIGHT DECREASED 200 0.0007
403 DYSPNOEA 405 0.0007
404 NECK MASS 2 0.0007
405 THROMBOCYTOPENIA 79 0.0007
406 HAND FRACTURE 5 0.0007
407 ABSCESS LIMB 3 0.0007
408 DERMATITIS CONTACT 8 0.0007
409 PNEUMATOSIS INTESTINALIS 2 0.0007
410 LEUKOPENIA 35 0.0007
411 ESCHERICHIA SEPSIS 2 0.0007
412 TREATMENT NONCOMPLIANCE 37 0.0007
413 CREPITATIONS 2 0.0007
414 ENDOPHTHALMITIS 4 0.0007
415 METABOLIC ENCEPHALOPATHY 2 0.0007
416 PAIN IN EXTREMITY 196 0.0007
417 MYELOFIBROSIS 2 0.0007
418 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
419 DYSAESTHESIA 2 0.0007
420 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
421 ENCEPHALOPATHY 16 0.0007
422 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
423 SPINAL DISORDER 6 0.0006
424 ABDOMINAL ADHESIONS 2 0.0006
425 BLADDER PAIN 2 0.0006
426 DIABETIC NEUROPATHY 3 0.0006
427 PELVIC PAIN 11 0.0006
428 ABDOMINAL TENDERNESS 3 0.0006
429 THERAPEUTIC AGENT TOXICITY 2 0.0006
430 HYPOAESTHESIA ORAL 9 0.0006
431 NECK PAIN 33 0.0006
432 HEADACHE 370 0.0006
433 PSEUDOMONAS INFECTION 5 0.0006
434 TENDERNESS 6 0.0006
435 CAROTID ARTERY STENOSIS 2 0.0006
436 NECROTISING FASCIITIS 2 0.0006
437 SEASONAL ALLERGY 8 0.0006
438 GASTROINTESTINAL INFECTION 5 0.0006
439 ANAL ABSCESS 3 0.0006
440 DECREASED ACTIVITY 6 0.0006
441 DIARRHOEA 357 0.0006
442 LIVER TRANSPLANT 2 0.0005
443 DIZZINESS 273 0.0005
444 AUTISM SPECTRUM DISORDER 3 0.0005
445 HYPERKERATOSIS 3 0.0005
446 HYPOKALAEMIA 25 0.0005
447 NEPHROPATHY 5 0.0005
448 BONE DENSITY ABNORMAL 2 0.0005
449 PARANASAL SINUS DISCOMFORT 2 0.0005
450 ECONOMIC PROBLEM 8 0.0005
451 OSTEOPENIA 8 0.0005
452 CLAVICLE FRACTURE 2 0.0005
453 RALES 3 0.0005
454 PANIC DISORDER 2 0.0005
455 OFF LABEL USE 447 0.0005
456 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
457 RESPIRATORY ACIDOSIS 2 0.0005
458 FURUNCLE 4 0.0005
459 INABILITY TO AFFORD MEDICATION 5 0.0005
460 BLEPHARITIS 2 0.0005
461 ARTERIOSPASM CORONARY 2 0.0005
462 HEPATIC FAILURE 15 0.0005
463 DEAFNESS 13 0.0005
464 FUNGAL SKIN INFECTION 2 0.0005
465 MUSCLE TIGHTNESS 8 0.0005
466 EAR DISCOMFORT 5 0.0005
467 HYPERPYREXIA 2 0.0005
468 BUNDLE BRANCH BLOCK LEFT 2 0.0005
469 FACIAL PARALYSIS 4 0.0005
470 PROCEDURAL PAIN 13 0.0005
471 PULMONARY TUBERCULOSIS 2 0.0005
472 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
473 OCULAR ICTERUS 2 0.0005
474 RASH PRURITIC 25 0.0005
475 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
476 SKIN SWELLING 4 0.0005
477 POLYP 3 0.0005
478 GINGIVAL SWELLING 2 0.0005
479 VULVOVAGINAL DISCOMFORT 2 0.0005
480 ACCIDENT AT WORK 1 0.0005
481 PHYSICAL DISABILITY 2 0.0005
482 SKIN MASS 3 0.0004
483 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
484 URINARY INCONTINENCE 13 0.0004
485 SYNOVIAL CYST 2 0.0004
486 DEFORMITY 4 0.0004
487 EYE PAIN 24 0.0004
488 INTENTIONAL PRODUCT MISUSE 37 0.0004
489 COLITIS 16 0.0004
490 NEUTROPENIC SEPSIS 3 0.0004
491 HOSPITALISATION 64 0.0004
492 GASTROINTESTINAL TOXICITY 2 0.0004
493 TINNITUS 19 0.0004
494 RASH PUSTULAR 3 0.0004
495 NAUSEA 324 0.0004
496 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
497 FEBRILE NEUTROPENIA 27 0.0004
498 EYE SWELLING 15 0.0004
499 CORONARY ARTERY STENOSIS 2 0.0004
500 LACRIMATION INCREASED 12 0.0004
501 PERITONITIS BACTERIAL 4 0.0004
502 INSURANCE ISSUE 6 0.0004
503 SLUGGISHNESS 4 0.0004
504 LIPASE INCREASED 3 0.0004
505 RENAL FAILURE CHRONIC 3 0.0004
506 CEREBRAL ISCHAEMIA 2 0.0004
507 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
508 GASTROENTERITIS VIRAL 7 0.0004
509 VARICOSE VEIN 2 0.0004
510 EYE PRURITUS 13 0.0004
511 POOR VENOUS ACCESS 4 0.0004
512 PELVIC FRACTURE 3 0.0004
513 OCULAR HYPERAEMIA 18 0.0004
514 BLOOD ALBUMIN DECREASED 3 0.0004
515 CHEILITIS 2 0.0004
516 ERYTHEMA OF EYELID 2 0.0004
517 ABDOMINAL RIGIDITY 1 0.0004
518 SKIN LACERATION 4 0.0004
519 HYDROCEPHALUS 2 0.0004
520 ASPIRATION 4 0.0004
521 DEAFNESS UNILATERAL 2 0.0004
522 SPINAL COMPRESSION FRACTURE 3 0.0004
523 HEPATOTOXICITY 8 0.0004
524 MALNUTRITION 4 0.0004
525 ACUTE PULMONARY OEDEMA 2 0.0004
526 SKIN PLAQUE 3 0.0004
527 LYMPHOPENIA 5 0.0004
528 CHOLECYSTITIS ACUTE 2 0.0004
529 BONE DENSITY DECREASED 11 0.0004
530 CARDIAC VALVE DISEASE 2 0.0003
531 ANAPHYLACTIC SHOCK 9 0.0003
532 SKIN ULCER 9 0.0003
533 EXERCISE TOLERANCE DECREASED 2 0.0003
534 CARDIAC MURMUR 3 0.0003
535 ENTEROCOLITIS 2 0.0003
536 SPINAL OSTEOARTHRITIS 3 0.0003
537 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
538 ABDOMINAL DISTENSION 35 0.0003
539 ANAL INCONTINENCE 3 0.0003
540 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
541 PALLOR 9 0.0003
542 DERMATITIS ACNEIFORM 2 0.0003
543 SKIN LESION 9 0.0003
544 BREAST CANCER STAGE I 3 0.0003
545 CHOLANGITIS 2 0.0003
546 OLIGURIA 2 0.0003
547 ERYTHEMA MULTIFORME 3 0.0003
548 BACTERIAL INFECTION 6 0.0003
549 CATARACT 19 0.0003
550 ARTERIOSCLEROSIS 3 0.0003
551 NIGHTMARE 11 0.0003
552 PNEUMOTHORAX 5 0.0003
553 STEVENS-JOHNSON SYNDROME 7 0.0003
554 TOOTH DISORDER 7 0.0003
555 SCREAMING 2 0.0003
556 EYE IRRITATION 18 0.0003
557 PROCTALGIA 2 0.0003
558 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
559 DIZZINESS POSTURAL 3 0.0003
560 HEPATITIS ACUTE 2 0.0003
561 INFLAMMATORY BOWEL DISEASE 3 0.0003
562 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
563 GASTRITIS 8 0.0003
564 LIGAMENT SPRAIN 3 0.0003
565 CARDIAC FAILURE ACUTE 2 0.0003
566 COAGULOPATHY 5 0.0003
567 SPINAL FRACTURE 6 0.0003
568 CHOLECYSTITIS CHRONIC 2 0.0003
569 BREAST MASS 2 0.0003
570 HYPOTHERMIA 3 0.0003
571 CANDIDA INFECTION 5 0.0003
572 BLOOD TESTOSTERONE DECREASED 2 0.0003
573 CROHN'S DISEASE 2 0.0003
574 JOINT EFFUSION 2 0.0003
575 HAEMATOCHEZIA 16 0.0003
576 PERITONITIS 6 0.0003
577 HYPERBILIRUBINAEMIA 3 0.0003
578 ENCEPHALITIS 2 0.0003
579 LARGE INTESTINE POLYP 2 0.0003
580 MASS 4 0.0003
581 DEFAECATION URGENCY 2 0.0003
582 HYPERKALAEMIA 10 0.0003
583 INCONTINENCE 3 0.0003
584 PULMONARY TOXICITY 2 0.0003
585 RENAL FAILURE ACUTE 12 0.0003
586 DIALYSIS 4 0.0003
587 DRUG INEFFECTIVE 367 0.0003
588 HAEMATEMESIS 7 0.0003
589 UTERINE LEIOMYOMA 2 0.0003
590 HEPATITIS 7 0.0003
591 BACK PAIN 63 0.0003
592 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
593 NERVE INJURY 3 0.0003
594 COLON CANCER 4 0.0003
595 CORONARY ARTERY DISEASE 8 0.0003
596 ERYTHEMA 54 0.0003
597 CHOLECYSTECTOMY 3 0.0003
598 HAEMODYNAMIC INSTABILITY 2 0.0003
599 ACIDOSIS 2 0.0003
600 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
601 DEVICE RELATED INFECTION 4 0.0003
602 METASTASES TO LUNG 3 0.0003
603 GLAUCOMA 5 0.0003
604 FOOD ALLERGY 2 0.0003
605 HAEMOLYSIS 2 0.0003
606 SPINAL PAIN 3 0.0003
607 HYPOACUSIS 11 0.0003
608 MULTIPLE ALLERGIES 2 0.0003
609 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
610 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
611 BLOOD IRON DECREASED 3 0.0003
612 NASAL DISCOMFORT 2 0.0003
613 ULCER 4 0.0003
614 PRODUCT QUALITY ISSUE 34 0.0003
615 CONSTIPATION 54 0.0002
616 ABNORMAL FAECES 2 0.0002
617 SMALL INTESTINAL OBSTRUCTION 3 0.0002
618 HYPERAESTHESIA 2 0.0002
619 ESCHERICHIA INFECTION 2 0.0002
620 COUGH 68 0.0002
621 GENERALISED OEDEMA 3 0.0002
622 ACUTE CORONARY SYNDROME 2 0.0002
623 CYTOMEGALOVIRUS INFECTION 4 0.0002
624 PULMONARY HYPERTENSION 5 0.0002
625 BONE PAIN 14 0.0002
626 BLOOD UREA INCREASED 4 0.0002
627 ATRIAL SEPTAL DEFECT 2 0.0002
628 DERMATITIS 5 0.0002
629 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
630 BRAIN OEDEMA 3 0.0002
631 GASTRIC CANCER 6 0.0002
632 GENITAL HAEMORRHAGE 3 0.0002
633 RESPIRATORY FAILURE 17 0.0002
634 SKIN HYPERPIGMENTATION 2 0.0002
635 MUSCLE STRAIN 2 0.0002
636 PYELONEPHRITIS 2 0.0002
637 METASTASES TO LIVER 4 0.0002
638 EMOTIONAL DISORDER 7 0.0002
639 IMMUNOSUPPRESSION 2 0.0002
640 ADVERSE REACTION 3 0.0002
641 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
642 RASH MACULO-PAPULAR 5 0.0002
643 FACIAL PAIN 2 0.0002
644 JAUNDICE 6 0.0002
645 CELLULITIS 11 0.0002
646 RETINAL DETACHMENT 2 0.0002
647 MUSCLE TWITCHING 5 0.0002
648 UROSEPSIS 2 0.0002
649 MENTAL STATUS CHANGES 6 0.0002
650 COORDINATION ABNORMAL 3 0.0002
651 FLANK PAIN 2 0.0002
652 EYE DISORDER 7 0.0002
653 PHOTOPHOBIA 4 0.0002
654 BLOOD SODIUM DECREASED 4 0.0002
655 FOOT FRACTURE 4 0.0002
656 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
657 LOSS OF CONSCIOUSNESS 27 0.0002
658 FEELING JITTERY 4 0.0002
659 HERPES ZOSTER 12 0.0002
660 POST PROCEDURAL COMPLICATION 4 0.0002
661 SINUS BRADYCARDIA 2 0.0002
662 HAEMORRHOIDS 4 0.0002
663 PHARYNGEAL SWELLING 2 0.0002
664 CARDIOMYOPATHY 3 0.0002
665 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
666 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
667 UPPER LIMB FRACTURE 4 0.0002
668 HAEMORRHAGE INTRACRANIAL 3 0.0002
669 EYELID PTOSIS 2 0.0002
670 TOOTH ABSCESS 2 0.0002
671 MOTOR DYSFUNCTION 2 0.0002
672 HYPONATRAEMIA 11 0.0002
673 ANAEMIA 37 0.0002
674 TEMPERATURE INTOLERANCE 2 0.0002
675 HAEMATOMA 5 0.0002
676 PRODUCT USE COMPLAINT 3 0.0002
677 SCRATCH 2 0.0002
678 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
679 EATING DISORDER 4 0.0002
680 JOINT INJURY 4 0.0002
681 BODY HEIGHT DECREASED 2 0.0002
682 FEAR 5 0.0002
683 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
684 LIMB INJURY 5 0.0002
685 BLOOD CREATININE INCREASED 12 0.0002
686 MULTIPLE FRACTURES 3 0.0002
687 GASTROINTESTINAL PAIN 2 0.0002
688 EMOTIONAL DISTRESS 22 0.0002
689 TOOTH FRACTURE 2 0.0002
690 DRY EYE 9 0.0002
691 VENTRICULAR FIBRILLATION 2 0.0002
692 DEHYDRATION 24 0.0002
693 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
694 PALPITATIONS 21 0.0002
695 RENAL IMPAIRMENT 15 0.0002
696 RASH PAPULAR 4 0.0002
697 INTESTINAL PERFORATION 2 0.0002
698 NEPHROPATHY TOXIC 2 0.0002
699 OCULAR DISCOMFORT 2 0.0002
700 BLOOD CALCIUM DECREASED 2 0.0002
701 EYE INFECTION 2 0.0002
702 HEMIPARESIS 3 0.0002
703 STATUS EPILEPTICUS 2 0.0002
704 MITRAL VALVE INCOMPETENCE 2 0.0002
705 DISORIENTATION 7 0.0002
706 INTENTIONAL DOSE OMISSION 5 0.0002
707 SCAR 3 0.0002
708 INTERNAL HAEMORRHAGE 2 0.0002
709 VISION BLURRED 24 0.0002
710 NEPHROLITHIASIS 8 0.0002
711 MUSCULOSKELETAL DISCOMFORT 3 0.0002
712 NEOPLASM 2 0.0002
713 ELECTROLYTE IMBALANCE 2 0.0002
714 LIVER FUNCTION TEST ABNORMAL 5 0.0002
715 RENAL DISORDER 8 0.0002
716 DERMATITIS ATOPIC 9 0.0002
717 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
718 DEEP VEIN THROMBOSIS 11 0.0002
719 BACTERAEMIA 2 0.0002
720 GALLBLADDER DISORDER 3 0.0002
721 MUSCLE RIGIDITY 2 0.0002
722 WRIST FRACTURE 2 0.0002
723 RESTLESS LEGS SYNDROME 3 0.0002
724 NOCTURIA 2 0.0002
725 BONE DISORDER 3 0.0002
726 ANAPHYLACTIC REACTION 9 0.0002
727 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
728 DYSGEUSIA 12 0.0002
729 ILEUS 2 0.0002
730 EPISTAXIS 12 0.0002
731 AGEUSIA 4 0.0002
732 INJECTION SITE REACTION 11 0.0002
733 DERMATITIS ALLERGIC 2 0.0002
734 FLATULENCE 9 0.0002
735 ABDOMINAL PAIN LOWER 4 0.0002
736 GASTRIC ULCER 3 0.0002
737 PROTEINURIA 3 0.0002
738 NEUROPATHY PERIPHERAL 15 0.0002
739 METABOLIC ACIDOSIS 5 0.0002
740 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
741 INFUSION SITE PAIN 2 0.0002
742 RASH GENERALISED 4 0.0002
743 HIATUS HERNIA 2 0.0002
744 ORAL HERPES 3 0.0002
745 PLATELET COUNT INCREASED 2 0.0002
746 NODULE 2 0.0002
747 SKIN DISCOLOURATION 7 0.0002
748 HEART RATE INCREASED 15 0.0002
749 HAEMATOCRIT DECREASED 3 0.0002
750 BLOOD PRESSURE ABNORMAL 3 0.0002
751 LIP SWELLING 5 0.0001
752 AGITATION 11 0.0001
753 MALIGNANT MELANOMA 2 0.0001
754 QUALITY OF LIFE DECREASED 2 0.0001
755 BLOOD BILIRUBIN INCREASED 4 0.0001
756 UVEITIS 2 0.0001
757 DISEASE RECURRENCE 7 0.0001
758 DRUG TOXICITY 2 0.0001
759 IMPAIRED GASTRIC EMPTYING 2 0.0001
760 HAEMATURIA 5 0.0001
761 PERIPHERAL COLDNESS 2 0.0001
762 APPLICATION SITE RASH 2 0.0001
763 TOOTH LOSS 3 0.0001
764 DIVERTICULITIS 4 0.0001
765 HYPOMAGNESAEMIA 2 0.0001
766 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
767 HEPATOCELLULAR INJURY 2 0.0001
768 IMPAIRED WORK ABILITY 3 0.0001
769 THERAPY INTERRUPTED 10 0.0001
770 RED BLOOD CELL COUNT DECREASED 4 0.0001
771 ANGINA PECTORIS 4 0.0001
772 IMPAIRED QUALITY OF LIFE 2 0.0001
773 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
774 SEPTIC SHOCK 6 0.0001
775 MENTAL DISORDER 6 0.0001
776 HYPOKINESIA 2 0.0001
777 PRODUCT PRESCRIBING ISSUE 3 0.0001
778 GASTROENTERITIS 2 0.0001
779 DYSSTASIA 4 0.0001
780 ACCIDENTAL OVERDOSE 5 0.0001
781 SURGERY 8 0.0001
782 MELAENA 3 0.0001
783 DYSURIA 5 0.0001
784 ANGIOEDEMA 6 0.0001
785 MYALGIA 23 0.0001
786 ORAL PAIN 3 0.0001
787 ECZEMA 7 0.0001
788 BONE LOSS 2 0.0001
789 BLOOD POTASSIUM DECREASED 4 0.0001
790 DYSARTHRIA 5 0.0001
791 HEART RATE IRREGULAR 3 0.0001
792 INTESTINAL OBSTRUCTION 5 0.0001
793 UNEVALUABLE EVENT 10 0.0001
794 BLOOD COUNT ABNORMAL 2 0.0001
795 PRODUCT AVAILABILITY ISSUE 3 0.0001
796 PLEURAL EFFUSION 8 0.0001
797 SHOCK 3 0.0001
798 THYROID DISORDER 2 0.0001
799 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
800 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
801 THERAPY PARTIAL RESPONDER 2 0.0001
802 BASAL CELL CARCINOMA 2 0.0001
803 MENINGIOMA 2 0.0001
804 BALANCE DISORDER 11 0.0001
805 CYANOSIS 2 0.0001
806 CHEST DISCOMFORT 13 0.0001
807 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
808 ILLNESS 13 0.0001
809 HALLUCINATION, AUDITORY 2 0.0001
810 SEPSIS 14 0.0001
811 ABSCESS 2 0.0001
812 HYPOTHYROIDISM 4 0.0001
813 LOCALISED INFECTION 3 0.0001
814 BLOOD POTASSIUM INCREASED 2 0.0001
815 SWELLING FACE 8 0.0001
816 STAPHYLOCOCCAL INFECTION 4 0.0001
817 BLOOD PRESSURE DECREASED 8 0.0001
818 SKIN DISORDER 4 0.0001
819 URINARY RETENTION 4 0.0001
820 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
821 ERECTILE DYSFUNCTION 3 0.0001
822 GASTRIC DISORDER 4 0.0001
823 UNRESPONSIVE TO STIMULI 3 0.0001
824 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
825 DEATH 99 0.0001
826 LOCAL SWELLING 2 0.0001
827 BRADYCARDIA 6 0.0001
828 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
829 HEAD DISCOMFORT 2 0.0001
830 DRUG ERUPTION 2 0.0001
831 OSTEOMYELITIS 2 0.0001
832 PNEUMONITIS 3 0.0001
833 SYNCOPE 11 0.0001
834 PANIC ATTACK 4 0.0001
835 RESPIRATORY ARREST 3 0.0001
836 RESPIRATORY DISTRESS 3 0.0001
837 FEELING COLD 3 0.0001
838 AGRANULOCYTOSIS 2 0.0001
839 THINKING ABNORMAL 2 0.0001
840 SKIN EXFOLIATION 9 0.0001
841 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
842 PAIN IN JAW 3 0.0001
843 URINARY TRACT INFECTION 18 0.0001
844 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
845 SLEEP APNOEA SYNDROME 2 0.0001
846 SOMNOLENCE 21 0.0001
847 ACUTE RESPIRATORY FAILURE 2 0.0001
848 ATRIAL FIBRILLATION 10 0.0001
849 SKIN FISSURES 2 0.0001
850 ASCITES 3 0.0001
851 ACUTE MYOCARDIAL INFARCTION 3 0.0001
852 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
853 DRUG INTERACTION 16 0.0001
854 TOXICITY TO VARIOUS AGENTS 17 0.0001
855 APHASIA 3 0.0001
856 PRODUCT ADMINISTRATION ERROR 2 0.0001
857 BLINDNESS 4 0.0001
858 THERAPY CESSATION 5 0.0001
859 PRODUCT PREPARATION ERROR 2 0.0001
860 CARDIAC ARREST 8 0.0001
861 FALL 32 0.0001
862 DEPRESSED MOOD 5 0.0001
863 PLATELET COUNT DECREASED 10 0.0001
864 MOVEMENT DISORDER 3 0.0001
865 PRURITUS GENERALISED 2 0.0001
866 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
867 PRODUCT DISPENSING ERROR 2 0.0001
868 DIABETES MELLITUS 7 0.0001
869 FEELING ABNORMAL 22 0.0001
870 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
871 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
872 CHOLELITHIASIS 3 0.0001
873 INFLUENZA 10 0.0001
874 PANCYTOPENIA 5 0.0001
875 PULMONARY OEDEMA 4 0.0001
876 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
877 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
878 CARDIAC FAILURE CONGESTIVE 7 0.0001
879 THROMBOSIS 7 0.0001
880 LETHARGY 5 0.0001
881 HEART RATE DECREASED 3 0.0001
882 NASAL CONGESTION 5 0.0001
883 BLOOD PRESSURE INCREASED 13 0.0001
884 ARRHYTHMIA 4 0.0001
885 TREMOR 14 0.0001
886 COMA 4 0.0001
887 PRODUCT PRESCRIBING ERROR 2 0.0001
888 PRODUCTIVE COUGH 4 0.0001
889 ACCIDENT 1 0.0001
890 BLOOD GLUCOSE DECREASED 4 0.0001
891 HEPATIC CANCER 2 0.0001
892 INTERSTITIAL LUNG DISEASE 4 0.0001
893 PRESYNCOPE 2 0.0001
894 NEURALGIA 2 0.0001
895 RESTLESSNESS 3 0.0001
896 CEREBRAL INFARCTION 2 0.0001
897 OSTEONECROSIS OF JAW 2 0.0001
898 PNEUMONIA ASPIRATION 2 0.0001
899 HYPOTENSION 16 0.0001
900 CARDIOVASCULAR DISORDER 2 0.0001
901 HYPOPHAGIA 2 0.0001
902 HAEMOGLOBIN DECREASED 8 0.0001
903 EXPOSURE VIA SKIN CONTACT 2 0.0001
904 DIPLOPIA 2 0.0001
905 CHILLS 9 0.0001
906 SPEECH DISORDER 4 0.0001
907 ABNORMAL BEHAVIOUR 3 0.0001
908 INJECTION SITE BRUISING 6 0.0001
909 NEOPLASM MALIGNANT 5 0.0001
910 CARDIAC FAILURE 6 0.0001
911 COVID-19 13 0.0001
912 POLLAKIURIA 3 0.0001
913 CARDIO-RESPIRATORY ARREST 3 0.0001
914 HAEMOPTYSIS 2 0.0001
915 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
916 CONVULSION 4 0.0001
917 HYPERSOMNIA 2 0.0001
918 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
919 VAGINAL HAEMORRHAGE 3 0.0001
920 NEEDLE ISSUE 2 0.0001
921 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
922 HALLUCINATION 5 0.0001
923 HOT FLUSH 5 0.0001
924 GYNAECOMASTIA 2 0.0001
925 LIMB DISCOMFORT 2 0.0001
926 FEMUR FRACTURE 2 0.0001
927 BREAST CANCER 6 0.0001
928 SWOLLEN TONGUE 2 0.0001
929 BLOOD GLUCOSE INCREASED 12 0.0001
930 HEAD INJURY 2 0.0001
931 PULMONARY EMBOLISM 6 0.0001
932 CYSTITIS 2 0.0001
933 HIP FRACTURE 2 0.0001
934 HYPOGLYCAEMIA 3 0.0001
935 OSTEONECROSIS 2 0.0001
936 INFLUENZA LIKE ILLNESS 5 0.0001
937 NO ADVERSE EVENT 11 0.0001
938 SEIZURE 7 0.0001
939 VIRAL INFECTION 2 0.0001
940 FUNGAL INFECTION 2 0.0001
941 CEREBROVASCULAR ACCIDENT 10 0.0001
942 BURNING SENSATION 4 0.0001
943 HYPOXIA 2 0.0001
944 LYMPHADENOPATHY 2 0.0001
945 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
946 CEREBRAL HAEMORRHAGE 2 0.0001
947 DISTURBANCE IN ATTENTION 3 0.0001
948 HYPERGLYCAEMIA 2 0.0001
949 SUICIDAL IDEATION 5 0.0001
950 DRUG DOSE OMISSION 9 0.0001
951 HYPERHIDROSIS 7 0.0001
952 OROPHARYNGEAL PAIN 5 0.0001
953 DYSPNOEA EXERTIONAL 2 0.0001
954 ACNE 4 0.0001
955 DRY SKIN 7 0.0001
956 PRODUCT SUBSTITUTION ISSUE 3 0.0001
957 PLASMA CELL MYELOMA 2 0.0001
958 DISEASE PROGRESSION 6 0.0001
959 DRUG DEPENDENCE 8 0.0000
960 PROSTATE CANCER 4 0.0000
961 DEVICE BREAKAGE 2 0.0000
962 FLUSHING 5 0.0000
963 NEUTROPHIL COUNT DECREASED 2 0.0000
964 OVERDOSE 10 0.0000
965 INJECTION SITE PRURITUS 3 0.0000
966 THROAT IRRITATION 2 0.0000
967 PRODUCT DOSE OMISSION ISSUE 13 0.0000
968 NEUTROPENIA 6 0.0000
969 COGNITIVE DISORDER 2 0.0000
970 CARDIAC DISORDER 4 0.0000
971 DYSPHAGIA 4 0.0000
972 RENAL CANCER 2 0.0000
973 SKIN BURNING SENSATION 3 0.0000
974 RASH ERYTHEMATOUS 2 0.0000
975 ABASIA 1 0.0000
976 AGGRESSION 2 0.0000
977 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
978 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
979 NERVOUSNESS 2 0.0000
980 ABNORMAL DREAMS 1 0.0000
981 MYOCARDIAL INFARCTION 6 0.0000
982 DYSPHONIA 2 0.0000
983 DEVICE ISSUE 3 0.0000
984 VERTIGO 2 0.0000
985 PRODUCT DOSE OMISSION 2 0.0000
986 INJECTION SITE SWELLING 2 0.0000
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
988 INJECTION SITE ERYTHEMA 3 0.0000
989 PRODUCT STORAGE ERROR 2 0.0000
990 INJECTION SITE PAIN 7 0.0000
991 DRUG WITHDRAWAL SYNDROME 2 0.0000
992 INCORRECT DOSE ADMINISTERED 5 0.0000
993 HAEMORRHAGE 2 0.0000